Sandbox Reserved 720: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 90: | Line 90: | ||
A mechanism that lowers merlin expression in breast cancer<ref>PMID:21965655</ref> is the phosphorylation at <scene name='Sandbox_Reserved_705/Resi/1'>Thr-230</scene> and <scene name='Sandbox_Reserved_705/Rez/1'>Ser-315</scene>. They target the protein for ubiquitination,degradation <ref>PMID:17891137</ref>. | A mechanism that lowers merlin expression in breast cancer<ref>PMID:21965655</ref> is the phosphorylation at <scene name='Sandbox_Reserved_705/Resi/1'>Thr-230</scene> and <scene name='Sandbox_Reserved_705/Rez/1'>Ser-315</scene>. They target the protein for ubiquitination,degradation <ref>PMID:17891137</ref>. | ||
However there exist many proteins that regulate merlin expression. They may all be | However there exist many proteins that regulate merlin expression. They may all be an useful therapetic target.Therefore further inverstigation are required to determine the pathways that involve the merlin protein. | ||
==External Resources== | ==External Resources== | ||
* See: [[Oncogenes & Tumor Suppressor Genes]] for Additional examples of oncogenes and tumor suppressor genes.<br /> | * See: [[Oncogenes & Tumor Suppressor Genes]] for Additional examples of oncogenes and tumor suppressor genes.<br /> | ||
* See: [[Cancer]] for Additional Proteins involved in the disease. <br /> | * See: [[Cancer]] for Additional Proteins involved in the disease. <br /> | ||
<ref group="xtra">PMID:22525268</ref><ref group="xtra">PMID:12356905</ref><ref group="xtra">PMID:12203111</ref><ref group="xtra">PMID:17134719</ref><ref group="xtra">PMID:14724586</ref><ref group="xtra">PMID:21402777</ref><ref group="xtra">PMID:10847681</ref> | |||
<references group="xtra"/> | <references group="xtra"/> | ||
